Cita APA (7th ed.)

Siebert, S., Coates, L., Schett, G., Raychaudhuri, S., Chen, W., Gao, S., . . . Deodhar, A. (2024). Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis. Wiley.

Cita Chicago (17th ed.)

Siebert, S., et al. Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis. Wiley, 2024.

Cita MLA (9th ed.)

Siebert, S., et al. Modulation of Interleukin‐23 Signaling With Guselkumab in Biologic‐Naive Patients Versus Tumor Necrosis Factor Inhibitor–Inadequate Responders With Active Psoriatic Arthritis. Wiley, 2024.